John Schilling, MBA, is a seventeen-year employee of Eli Lilly & Co., who currently is Director – Advisor of Diagnostics for the Personalized Medicine – Tailored Therapeutics Division within Lilly Research Laboratories. John is responsible for executing the global diagnostic personalized medicine strategy to enable the capabilities to deliver for the global drug teams across Lilly’s pharmaceutical business units. John’s prior responsibilities at Lilly have been as Global Marketing Director for the global Forteo and Evista brands.
Prior to Eli Lilly, John has worked as Marketing Director for Bausch & Lomb’s pharmaceutical division representing the anti-allergy and dry eye products. He also was U.S. Brand Manager for AstraZeneca’s Prilosec brand. Prior to John’s pharmaceutical experience, he worked in the diagnostic industry for Abbott Laboratories Diagnostics Division, Sanofi Diagnostics Pasteur, Bayer Diagnostics and Centocor in different sales, sales management, global marketing and business development roles.